Melanotan 2 (MT-2) 10mg

Melanotan 2 (MT-2) is a synthetic peptide analogue supplied as a lyophilised powder for laboratory research use. It is selected within controlled environments for investigation into peptide structure, receptor interaction, and signalling pathways.

Classification: Melanotan II — a synthetic cyclic heptapeptide analogue of α-melanocyte-stimulating hormone (α-MSH).

Within laboratory settings, Melanotan 2 is studied for its interaction with melanocortin receptors. Research applications focus on receptor binding activity, peptide stability, and signalling pathways associated with melanocortin system research under controlled experimental conditions.

This summary describes published preclinical and, where applicable, clinical research. It is not a medical claim and does not describe or endorse any human use of the compound as sold by Peptides UK 4U.

Melanotan II is studied in preclinical research as a non-selective agonist across melanocortin receptors (MC1R–MC5R). Published in vitro and animal-model work explores its receptor-binding profile, effects on melanogenesis via MC1R, and central melanocortin signalling. Presented as research background only.

This product is typically reconstituted using bacteriostatic water or a suitable sterile solvent within a controlled laboratory setting. All handling should be carried out by qualified professionals using appropriate sterile techniques and safety procedures.

Storage & stability

• Store in a cool, dry environment before reconstitution.
• For extended stability, storage at -20°C is recommended.
• Avoid repeated freeze-thaw cycles after reconstitution.

For reconstitution volumes and target working concentrations use our peptide calculator. We do not publish dosing protocols for human use.

Peptide Type

Synthetic melanocortin receptor agonist analogue

Form

Lyophilised powder

Quantity

10 mg

Purity

≥98% (subject to batch testing)

Appearance

White lyophilised powder

Solubility

Water soluble

Stability

Maintains integrity under controlled storage conditions

Manufacturing Standard

Produced in controlled laboratory environments

Certificate of Analysis: Available on request from our support team.

• Dorr RT et al., Life Sciences 58(20):1777–1784 (1996) — melanotan II pharmacology
• Hadley ME & Dorr RT, Peptides 27(4):921–930 (2006) — melanocortin analogues review

References are provided for educational context. Citation does not imply endorsement of any specific use.